Amyloid fibril formation can proceed from different conformations of a partially unfolded protein.
Protein misfolding and aggregation are interconnected processes involved in a wide variety of nonneuropathic, systemic, and neurodegenerative diseases. More generally, if mutations in sequence or changes in environmental conditions lead to partial unfolding of the native state of a protein, it will often aggregate, sometimes into well-defined fibrillar structures. A great deal of interest has been directed at discovering the characteristic features of metastable partially unfolded states that precede the aggregated states of proteins. In this work, human muscle acylphosphatase (AcP) has been first destabilized, by addition of urea or by means of elevated temperatures, and then incubated in the presence of different concentrations of 2,2,2, trifluoroethanol ranging from 5% to 25% (v/v). The results show that AcP is able to form both fibrillar and nonfibrillar aggregates with a high beta-sheet content from partially unfolded states with very different structural features. Moreover, the presence of alpha-helical structure in such a state does not appear to be a fundamental determinant of the ability to aggregate. The lack of ready aggregation under some of the conditions examined here is attributable primarily to the intrinsic properties of the solutions rather than to specific structural features of the partially unfolded states that precede aggregation. Aggregation appears to be favored when the solution conditions promote stable intermolecular interactions, particularly hydrogen bonds. In addition, the structures of the resulting aggregates are largely independent of the conformational properties of their soluble precursors.
Calamai
Martino
M
Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom.
Chiti
Fabrizio
F
Dobson
Christopher M
CM
D017766:Acid Anhydride Hydrolases / Q000032:analysis / Q000737:chemistry* / Q000648:ultrastructure*; D000682:Amyloid / Q000138:chemical synthesis* / Q000648:ultrastructure*; D019281:Dimerization; D006801:Humans; D046912:Multiprotein Complexes / Q000138:chemical synthesis; D018482:Muscle, Skeletal / Q000201:enzymology*; D011485:Protein Binding; D011487:Protein Conformation; D011489:Protein Denaturation; D017510:Protein Folding; D013696:Temperature; D000097024:Acylphosphatase
D017766:Acid Anhydride Hydrolases; D000682:Amyloid; D046912:Multiprotein Complexes; D000097024:Acylphosphatase